glimepiride has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Adeyemi, OO; Akande, AJ; Ishola, IO; Oduola-Akande, MD; Olubodun-Obadun, TG | 1 |
1 other study(ies) available for glimepiride and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Glimepiride Prevents 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Induced Dopamine Neurons Degeneration Through Attenuation of Glia Activation and Oxidative Stress in Mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Dopaminergic Neurons; Mice; Mice, Inbred C57BL; Neuroglia; Oxidative Stress; Parkinson Disease; Tyrosine 3-Monooxygenase | 2023 |